ONEX CORP SUB VOTING SHARES CANADA (OTCMKTS:ONEXF) had an increase of 9.56% in short interest. ONEXF’s SI was 203,900 shares in March as released by FINRA. Its up 9.56% from 186,100 shares previously. With 17,500 avg volume, 12 days are for ONEX CORP SUB VOTING SHARES CANADA (OTCMKTS:ONEXF)’s short sellers to cover ONEXF’s short positions. The SI to ONEX CORP SUB VOTING SHARES CANADA’s float is 0.21%. The stock increased 0.41% or $0.293 during the last trading session, reaching $71.818. About 4,048 shares traded. Onex Corporation (OTCMKTS:ONEXF) has 0.00% since March 30, 2017 and is . It has underperformed by 11.55% the S&P500.
The stock of Axovant Sciences Ltd. (NASDAQ:AXON) hit a new 52-week low and has $1.24 target or 7.00% below today’s $1.33 share price. The 5 months bearish chart indicates high risk for the $143.36 million company. The 1-year low was reported on Mar, 30 by Barchart.com. If the $1.24 price target is reached, the company will be worth $10.04M less. The stock decreased 1.48% or $0.02 during the last trading session, reaching $1.33. About 512,343 shares traded. Axovant Sciences Ltd. (NASDAQ:AXON) has declined 90.77% since March 30, 2017 and is downtrending. It has underperformed by 102.32% the S&P500.
Axovant Sciences Ltd., a clinical-stage biopharmaceutical company, engages in developing and commercializing medicines for the treatment of dementia and related neurological disorders in the United States and Europe. The company has market cap of $143.36 million. The Company’s lead product candidate, intepirdine, a selective 5-HT6 receptor antagonist, which is in Phase III clinical trial for the treatment of AlzheimerÂ’s disease; in Phase IIb clinical trial for treating dementia with Lewy bodies ; and in Phase II clinical trial for treating cait and balance in Alzheimer's disease, DLB, and Parkinson's disease dementia. It currently has negative earnings. The firm is also developing nelotanserin, a selective 5-HT2A receptor inverse agonist, which is in Phase II clinical trial for the treatment of visual hallucinations in patients with Lewy body dementia (LBD) and REM behavior disorder in patients with LBD.
Onex Corporation is a private equity firm specializing in acquisitions and platform acquisitions. The company has market cap of $7.19 billion. The firm makes investments in buyouts, large- middle market, large-cap, mid-cap, and small-cap market and distressed companies. It has a 3.06 P/E ratio. It also invests in recapitalization, growth capital, corporate carve-outs of subsidiaries and mission-critical supply divisions from multinational firms, operational restructurings of undervalued businesses, and manufactures up.
The post Axovant Sciences Ltd. (AXON) Reaches $1.33 52-Week Low; ONEX SUB VOTING SHARES CANADA (ONEXF) Shorts Raised By 9.56% appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/03/30/axovant-sciences-ltd-axon-reaches-1-33-52-week-low-onex-sub-voting-shares-canada-onexf-shorts-raised-by-9-56/
No comments:
Post a Comment